Join
Live feed
·
INSIDERFilingvia Quantisnow
Global Blood Therapeutics Inc. logo

SEC Form 4: Farrow Jeffrey S converted options into 4,971 shares, covered exercise/tax liability with 1,885 shares and sold $2,137,988 worth of shares (31,441 units at $68.00), decreasing direct ownership by 90% to 3,086 units to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GBT (Global Blood Therapeutics Inc.) and more on Quantisnow.